Reported Earnings • May 17
First quarter 2026 earnings released: EPS: €0.10 (vs €0.05 in 1Q 2025) First quarter 2026 results: EPS: €0.10 (up from €0.05 in 1Q 2025). Revenue: €310.5m (down 10% from 1Q 2025). Net income: €3.90m (up 106% from 1Q 2025). Profit margin: 1.3% (up from 0.5% in 1Q 2025). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Announcement • Apr 17
H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026 H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time. Reported Earnings • Apr 06
Full year 2025 earnings released: €1.04 loss per share (vs €0.28 profit in FY 2024) Full year 2025 results: €1.04 loss per share (down from €0.28 profit in FY 2024). Revenue: €1.28b (down 4.8% from FY 2024). Net loss: €38.8m (down 465% from profit in FY 2024). Revenue is forecast to grow 1.8% p.a. on average during the next 2 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Price Target Changed • Jan 28
Price target decreased by 13% to €4.50 Down from €5.20, the current price target is an average from 2 analysts. New target price is 6.4% above last closing price of €4.23. Stock is up 13% over the past year. The company is forecast to post earnings per share of €0.08 for next year compared to €0.29 last year. Reported Earnings • Nov 17
Third quarter 2025 earnings released: €0.02 loss per share (vs €0.09 profit in 3Q 2024) Third quarter 2025 results: €0.02 loss per share (down from €0.09 profit in 3Q 2024). Revenue: €320.0m (down 5.3% from 3Q 2024). Net loss: €662.0k (down 119% from profit in 3Q 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 17
Second quarter 2025 earnings released: €0.04 loss per share (vs €0.037 profit in 2Q 2024) Second quarter 2025 results: €0.04 loss per share (down from €0.037 profit in 2Q 2024). Revenue: €319.9m (down 3.6% from 2Q 2024). Net loss: €1.63m (down 226% from profit in 2Q 2024). Revenue is forecast to stay flat during the next 2 years compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. Upcoming Dividend • May 21
Upcoming dividend of €0.10 per share Eligible shareholders must have bought the stock before 28 May 2025. Payment date: 30 May 2025. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%). Reported Earnings • May 16
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: EPS: €0.28 (up from €0.28 in FY 2023). Revenue: €1.35b (down 1.1% from FY 2023). Net income: €10.6m (flat on FY 2023). Profit margin: 0.8% (in line with FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 61%. Revenue is forecast to stay flat during the next 2 years compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to €4.97, the stock trades at a trailing P/E ratio of 17.4x. Average forward P/E is 17x in the Chemicals industry in Germany. Total loss to shareholders of 8.3% over the past three years. Price Target Changed • May 11
Price target decreased by 8.8% to €5.20 Down from €5.70, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €3.96. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.29 last year. Announcement • Apr 17
H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 H&R GmbH & Co. KGaA announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025. Announcement • Apr 16
H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025 H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time. Reported Earnings • Apr 10
Full year 2024 earnings released: EPS: €0.29 (vs €0.28 in FY 2023) Full year 2024 results: EPS: €0.29 (up from €0.28 in FY 2023). Revenue: €1.38b (up 1.0% from FY 2023). Net income: €10.6m (flat on FY 2023). Profit margin: 0.8% (in line with FY 2023). Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to €3.59, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in Germany. Total loss to shareholders of 35% over the past three years. Valuation Update With 7 Day Price Move • Mar 17
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €4.35, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Germany. Total loss to shareholders of 33% over the past three years. Reported Earnings • Nov 17
Third quarter 2024 earnings released: EPS: €0.09 (vs €0.20 in 3Q 2023) Third quarter 2024 results: EPS: €0.09 (down from €0.20 in 3Q 2023). Revenue: €348.7m (up 3.4% from 3Q 2023). Net income: €3.52m (down 54% from 3Q 2023). Profit margin: 1.0% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings. Major Estimate Revision • Oct 15
Consensus revenue estimates fall by 12% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €1.52b to €1.35b. EPS estimate fell from €0.39 to €0.25 per share. Net income forecast to grow 29% next year vs 59% growth forecast for Chemicals industry in Germany. Consensus price target up from €5.00 to €5.70. Share price was steady at €3.72 over the past week. Reported Earnings • Aug 16
Second quarter 2024 earnings released: EPS: €0.03 (vs €0.13 in 2Q 2023) Second quarter 2024 results: EPS: €0.03 (down from €0.13 in 2Q 2023). Revenue: €347.5m (flat on 2Q 2023). Net income: €1.30m (down 72% from 2Q 2023). Profit margin: 0.4% (down from 1.3% in 2Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €4.14, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 54% over the past three years. Upcoming Dividend • May 22
Upcoming dividend of €0.10 per share Eligible shareholders must have bought the stock before 29 May 2024. Payment date: 31 May 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%). Reported Earnings • May 17
First quarter 2024 earnings released: EPS: €0.04 (vs €0.03 loss in 1Q 2023) First quarter 2024 results: EPS: €0.04 (up from €0.03 loss in 1Q 2023). Revenue: €343.7m (down 1.5% from 1Q 2023). Net income: €1.47m (up €2.42m from 1Q 2023). Profit margin: 0.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: €0.28 (down from €1.15 in FY 2022). Revenue: €1.35b (down 15% from FY 2022). Net income: €10.6m (down 75% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Declared Dividend • Mar 30
Dividend of €0.10 announced Dividend of €0.10 is the same as last year. Ex-date: 29th May 2024 Payment date: 31st May 2024 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 53% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Major Estimate Revision • Dec 20
Consensus EPS estimates increase by 18%, revenue downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €1.32b to €1.27b. EPS estimate rose from €0.565 to €0.665. Net income forecast to grow 69% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price rose 11% to €4.80 over the past week. Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: €0.13 (vs €0.58 in 2Q 2022) Second quarter 2023 results: EPS: €0.13 (down from €0.58 in 2Q 2022). Revenue: €358.1m (down 19% from 2Q 2022). Net income: €4.69m (down 78% from 2Q 2022). Profit margin: 1.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Upcoming Dividend • May 17
Upcoming dividend of €0.10 per share at 1.9% yield Eligible shareholders must have bought the stock before 24 May 2023. Payment date: 26 May 2023. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%). Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to €5.12, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 24% over the past three years. Buying Opportunity • Apr 26
Now 28% undervalued after recent price drop Over the last 90 days, the stock is down 9.6%. The fair value is estimated to be €7.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 13% in 2 years. Earnings is forecast to decline by 64% in the next 2 years. Buying Opportunity • Apr 04
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 2.5%. The fair value is estimated to be €7.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 12% in 2 years. Earnings is forecast to decline by 64% in the next 2 years. Reported Earnings • Apr 02
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: €1.15 (down from €1.35 in FY 2021). Revenue: €1.58b (up 32% from FY 2021). Net income: €42.7m (down 15% from FY 2021). Profit margin: 2.7% (down from 4.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is expected to decline by 6.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Mar 01
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 3.9%. The fair value is estimated to be €7.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years. Buying Opportunity • Feb 13
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 7.3%. The fair value is estimated to be €7.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years. Buying Opportunity • Jan 18
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 6.2%. The fair value is estimated to be €7.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years. Major Estimate Revision • Nov 16
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.73 to €1.01. Revenue forecast unchanged at €1.57b. Net income forecast to shrink 48% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price was steady at €6.56 over the past week. Reported Earnings • Aug 17
Second quarter 2022 earnings released: EPS: €0.58 (vs €0.64 in 2Q 2021) Second quarter 2022 results: EPS: €0.58 (down from €0.64 in 2Q 2021). Revenue: €453.6m (up 43% from 2Q 2021). Net income: €21.6m (down 8.8% from 2Q 2021). Profit margin: 4.8% (down from 7.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Jul 27
Consensus EPS estimates increase by 59% The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from €1.54b to €1.57b. EPS estimate increased from €0.46 to €0.73 per share. Net income forecast to shrink 54% next year vs 4.5% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price rose 6.0% to €6.40 over the past week. Major Estimate Revision • May 20
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €1.39b to €1.54b. EPS estimate fell from €0.48 to €0.46. Net income forecast to shrink 71% next year vs 3.2% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price fell 2.4% to €5.64 over the past week. Reported Earnings • May 16
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: €0.22 (up from €0.19 in 1Q 2021). Revenue: €368.8m (up 53% from 1Q 2021). Net income: €8.09m (up 12% from 1Q 2021). Profit margin: 2.2% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Price Target Changed • Apr 27
Price target decreased to €7.25 Down from €8.25, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €5.82. Stock is down 21% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year. Major Estimate Revision • Apr 08
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €1.21b to €1.39b. EPS estimate fell from €0.51 to €0.48. Net income forecast to shrink 65% next year vs 4.3% decline forecast for Chemicals industry in Germany. Consensus price target down from €8.50 to €7.25. Share price fell 5.3% to €5.70 over the past week. Reported Earnings • Apr 01
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: €1.35 (up from €0.24 loss in FY 2020). Revenue: €1.19b (up 35% from FY 2020). Net income: €50.2m (up €59.2m from FY 2020). Profit margin: 4.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 1.8%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Feb 24
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €5.84, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 18% over the past three years. Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €6.76, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 4.0% over the past three years. Reported Earnings • Nov 17
Third quarter 2021 earnings released: EPS €0.43 (vs €0.03 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €325.2m (up 56% from 3Q 2020). Net income: €16.0m (up €17.3m from 3Q 2020). Profit margin: 4.9% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 6% per year. Major Estimate Revision • Jul 23
Consensus revenue estimates increase to €1.16b The consensus outlook for revenues in 2021 has improved. 2021 revenue forecast increased from €1.01b to €1.16b. EPS estimate increased from €0.27 to €1.30 per share. Net income forecast to grow 1,239% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target up from €8.50 to €11.00. Share price rose 11% to €9.34 over the past week. Reported Earnings • May 17
First quarter 2021 earnings released: EPS €0.19 (vs €0.13 loss in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: €248.5m (down 4.2% from 1Q 2020). Net income: €7.24m (up €12.0m from 1Q 2020). Profit margin: 2.9% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 24
Full year 2020 earnings released: €0.24 loss per share (vs €0.037 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €878.5m (down 19% from FY 2019). Net loss: €9.02m (loss widened €7.65m from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. Price Target Changed • Feb 03
Price target raised to €6.65 Up from €5.90, the current price target is an average from 2 analysts. The new target price is 9.4% above the current share price of €6.08. As of last close, the stock is up 16% over the past year. Is New 90 Day High Low • Jan 21
New 90-day high: €6.10 The company is up 30% from its price of €4.71 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.12 per share. Is New 90 Day High Low • Jan 05
New 90-day high: €5.75 The company is up 14% from its price of €5.03 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.10 per share. Is New 90 Day High Low • Nov 27
New 90-day high: €5.70 The company is up 9.0% from its price of €5.22 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.38 per share. Analyst Estimate Surprise Post Earnings • Nov 17
Revenue and earnings miss expectations Revenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Reported Earnings • Nov 17
Third quarter 2020 earnings released: €0.03 loss per share The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2020 results: Revenue: €213.3m (down 22% from 3Q 2019). Net loss: €1.21m (loss narrowed 80% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Oct 15
New 90-day low: €4.84 The company is down 19% from its price of €5.97 on 17 July 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.46 per share. Announcement • Oct 05
H&R Wasag AG to Report Fiscal Year 2009 Results on 03/30/2010 H&R Wasag AG announced that they will report fiscal year 2009 results on 03/30/2010 Is New 90 Day High Low • Sep 26
New 90-day low: €5.14 The company is down 1.0% from its price of €5.21 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.44 per share.